BRD4 (Bromodomain-Containing Protein 4)
<div class="infobox infobox-gene">
<h3>BRD4</h3>
<table> [@nicodeme2010]
<tr><td><strong>Full Name</strong></td><td>Bromodomain-Containing Protein 4</td></tr> [@demars2019]
<tr><td><strong>Gene Symbol</strong></td><td>BRD4</td></tr> [@korb2015]
<tr><td><strong>Chromosomal Location</strong></td><td>19p13.12</td></tr> [@sullivan2015]
<tr><td><strong>NCBI Gene ID</strong></td><td>[23476](https://www.ncbi.nlm.nih.gov/gene/23476)</td></tr> [@filippakopoulos2010]
<tr><td><strong>OMIM</strong></td><td>[608749](https://omim.org/entry/608749)</td></tr> [@hnisz2013]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000141867](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141867)</td></tr> [@sabari2018]
<tr><td><strong>UniProt</strong></td><td>[O60885](https://www.uniprot.org/uniprot/O60885)</td></tr> [@belkina2012]
<tr><td><strong>Protein</strong></td><td>Bromodomain-containing protein 4</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Huntington's disease](/diseases/huntingtons-disease), neuroinflammation</td></tr>
</table>
</div>
Overview
BDNF is a human gene. Variants in BDNF have been implicated in Alzheimer's Disease, Parkinson's Disease, Huntington's Disease. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
Pathway Diagram
...BRD4 (Bromodomain-Containing Protein 4)
<div class="infobox infobox-gene">
<h3>BRD4</h3>
<table> [@nicodeme2010]
<tr><td><strong>Full Name</strong></td><td>Bromodomain-Containing Protein 4</td></tr> [@demars2019]
<tr><td><strong>Gene Symbol</strong></td><td>BRD4</td></tr> [@korb2015]
<tr><td><strong>Chromosomal Location</strong></td><td>19p13.12</td></tr> [@sullivan2015]
<tr><td><strong>NCBI Gene ID</strong></td><td>[23476](https://www.ncbi.nlm.nih.gov/gene/23476)</td></tr> [@filippakopoulos2010]
<tr><td><strong>OMIM</strong></td><td>[608749](https://omim.org/entry/608749)</td></tr> [@hnisz2013]
<tr><td><strong>Ensembl</strong></td><td>[ENSG00000141867](https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000141867)</td></tr> [@sabari2018]
<tr><td><strong>UniProt</strong></td><td>[O60885](https://www.uniprot.org/uniprot/O60885)</td></tr> [@belkina2012]
<tr><td><strong>Protein</strong></td><td>Bromodomain-containing protein 4</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>[Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), [Huntington's disease](/diseases/huntingtons-disease), neuroinflammation</td></tr>
</table>
</div>
Overview
BDNF is a human gene. Variants in BDNF have been implicated in Alzheimer's Disease, Parkinson's Disease, Huntington's Disease. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
Pathway Diagram
Mermaid diagram (expand to render)
Gene Function
BRD4 encodes a member of the bromodomain and extra-terminal domain (BET) protein family that functions as an epigenetic reader of acetylated histones and a master regulator of transcriptional elongation. BRD4 contains two tandem bromodomains (BD1 and BD2) that recognize acetylated lysine residues on histones H3 and H4, as well as an extra-terminal (ET) domain that recruits transcriptional regulators.
BRD4 plays essential roles in gene regulation through several mechanisms:
- Transcriptional elongation: BRD4 recruits the positive transcription elongation factor b (P-TEFb/CDK9) to acetylated chromatin, stimulating RNA Polymerase II elongation and releasing promoter-proximal pausing at thousands of genes
- Super-enhancer regulation: BRD4 is disproportionately concentrated at super-enhancers — large clusters of enhancers that drive cell-identity genes. In [neurons](/entities/neurons), super-enhancers control [BDNF](/genes/bdnf), synaptic receptor genes, and ion channel genes
- Inflammatory gene activation: BRD4 is recruited to [NF-κB](/entities/nf-kb)-responsive promoters during inflammation, serving as a co-activator for pro-inflammatory transcription
- Bookmarking during mitosis: BRD4 remains bound to acetylated chromatin during mitosis, "bookmarking" active genes for rapid reactivation after cell division
- Phase separation: BRD4 undergoes liquid-liquid phase separation to form transcriptional condensates at super-enhancers, concentrating transcriptional machinery
In the brain, BRD4 is essential for activity-dependent gene expression, synaptic plasticity, and learning/memory formation.
Disease Associations
Alzheimer's Disease
BRD4 is aberrantly upregulated in [AD](/diseases/alzheimers-disease) brain, particularly in [microglia](/cell-types/microglia-neuroinflammation) and [astrocytes](/entities/astrocytes), where it drives neuroinflammatory transcription:
- NF-κB-dependent inflammation: BRD4 is required for sustained NF-κB transcriptional activity; it binds acetylated RelA/p65 and recruits P-TEFb to inflammatory gene promoters including [TNF](/genes/tnf), [IL-6](/genes/il6), [IL-1β](/genes/il1b), and complement components
- Amyloid-driven BRD4 activation: Amyloid-β oligomers activate BRD4 through NF-κB and p38-MAPK signaling, creating a feed-forward inflammatory loop
- [Tau](/proteins/tau)-related epigenetic dysregulation: Pathological [tau](/genes/mapt) disrupts nuclear BRD4 distribution, altering super-enhancer landscapes and gene expression in tauopathy models
- Synaptic gene dysregulation: BRD4 redistribution in AD neurons leads to loss of BRD4 at synaptic gene super-enhancers and gain at stress-response and inflammatory loci
- BRD4 inhibition is neuroprotective: BET inhibitors (JQ1, I-BET858) reduce neuroinflammation, amyloid plaque burden, and cognitive decline in AD mouse models
Parkinson's Disease
In [PD](/diseases/parkinsons-disease), BRD4 contributes to neurodegeneration through:
- Amplification of [α-synuclein](/proteins/alpha-synuclein)-induced microglial inflammation via NF-κB coactivation
- Epigenetic dysregulation in dopaminergic neurons — BRD4 mislocalization alters expression of dopaminergic identity genes ([TH](/genes/th), [NURR1](/genes/nr4a2))
- BET inhibitors (JQ1) attenuate MPTP-induced dopaminergic neuronal death and microglial activation in PD models
- BRD4 regulates [LRRK2](/genes/lrrk2) expression; gain-of-function [LRRK2](/entities/lrrk2) mutations alter BRD4-dependent transcription
Huntington's Disease
BRD4 dysfunction is prominent in [HD](/diseases/huntingtons):
- Mutant [huntingtin](/proteins/huntingtin) (mHTT) sequesters BRD4 into intranuclear inclusions, depleting it from active chromatin
- BRD4 depletion disrupts super-enhancer-driven transcription of striatal identity genes, contributing to medium spiny neuron vulnerability
- BET inhibitors paradoxically improve HD phenotypes by redistributing remaining BRD4 to critical gene loci
Amyotrophic Lateral Sclerosis
BRD4 drives neuroinflammation in [ALS](/diseases/amyotrophic-lateral-sclerosis) spinal cord:
- Microglia in ALS tissue show elevated BRD4 binding at inflammatory gene promoters
- BET inhibitors reduce motor neuron degeneration in SOD1-G93A mouse models
- [TDP-43](/genes/tardbp) and [FUS](/entities/fus) pathology alter BRD4-dependent RNA processing
Expression Profile
BRD4 is ubiquitously expressed but shows dynamic regulation in the brain:
- Cortical neurons — Constitutive expression; rapidly redistributes to activity-dependent gene loci upon neuronal stimulation
- Microglia — Low basal expression; dramatically upregulated upon activation (LPS, [Aβ](/proteins/amyloid-beta), α-synuclein)
- Astrocytes — Moderate expression; increases during reactive astrogliosis
- [Hippocampus](/brain-regions/hippocampus) — High expression in CA1 pyramidal neurons; required for spatial learning and memory consolidation
- Striatum — Medium spiny neurons show high BRD4 occupancy at super-enhancers for striatal identity genes
- Substantia nigra — Expressed in dopaminergic neurons and surrounding glia
BRD4 expression and chromatin binding are dynamically regulated by neuronal activity, stress, and inflammatory signals. The short isoform (BRD4-S) and long isoform (BRD4-L) have distinct functions, with BRD4-L containing the C-terminal P-TEFb interaction domain essential for transcriptional elongation.
Common Variants and Risk Alleles
| Variant | Type | Association | Effect |
|---------|------|-------------|--------|
| rs4808278 | Intronic | Neuroinflammatory susceptibility | Altered BRD4 expression |
| rs2304620 | 5' UTR | AD risk (suggestive) | Modified BRD4 translation efficiency |
| rs1062966 | 3' UTR | Inflammatory gene regulation | Altered miRNA binding site |
Therapeutic Implications
BRD4 has emerged as one of the most promising epigenetic drug targets for neurodegenerative diseases:
- JQ1: Prototype BET bromodomain inhibitor; potent anti-inflammatory effects in AD and PD models. Crosses the [blood-brain barrier](/entities/blood-brain-barrier). Reduces Aβ plaque burden, tau phosphorylation, and microglial activation. However, pan-BET inhibition causes side effects including thrombocytopenia
- I-BET858: Selective BET inhibitor with improved pharmacokinetics; shows efficacy in AD mouse models with reduced peripheral side effects
- ABBV-744 (BD2-selective): Selectively inhibits the second bromodomain of BET proteins, potentially dissociating anti-inflammatory effects from transcriptional toxicity
- BRD4 PROTACs (dBET1, ARV-825): Targeted protein degradation of BRD4; potent anti-inflammatory effects but require careful dosing to avoid neuronal transcriptional collapse
- CPI-0610 (pelabresib): Clinical-stage BET inhibitor with potential neurological applications
- Combination strategies: BRD4 inhibition combined with [HDAC inhibitors](/genes/hdac1) or anti-amyloid therapy may achieve synergistic neuroprotection
See Also
- [HDAC1](/genes/hdac1) — Histone deacetylase, removes marks read by BRD4
- [CREBBP](/genes/crebbp) — Histone acetyltransferase, creates marks read by BRD4
- [EP300](/genes/ep300) — p300 acetyltransferase, acetylates BRD4 substrates
- [Chromatin Remodeling in Neurodegeneration](/mechanisms/chromatin-remodeling)
- [SIRT1](/genes/sirt1) — Sirtuin deacetylase, opposes BRD4 substrate generation
External Links
- [NCBI Gene: BRD4](https://www.ncbi.nlm.nih.gov/gene/23476)
- [GeneCards: BRD4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=BRD4)
- [Allen Brain Atlas: BRD4](https://human.brain-map.org/microarray/search/show?search_term=BRD4)
- [OMIM: 608749](https://omim.org/entry/608749)
References
[Magistri et al., The BET-bromodomain inhibitor JQ1 reduces inflammation and tau phosphorylation at Ser396 in the brain of the 3xTg model of Alzheimer's disease (2016) (2016)](https://doi.org/10.2174/1567205013666160603003913)
[Benner et al., Protective astrogenesis from the SVZ niche after injury is controlled by Notch modulator Thbs4 (2013) (2013)](https://doi.org/10.1038/nature12069)
[Nicodeme et al., Suppression of inflammation by a synthetic histone mimic (2010) (2010)](https://doi.org/10.1038/nature09589)
[DeMars et al., Neuroprotective effects of targeting BET proteins for degradation with dBET1 in aged mice subjected to ischemic stroke (2019) (2019)](https://doi.org/10.1016/j.neuint.2019.104539)
[Korb et al., BET protein Brd4 activates transcription in neurons and BET inhibitor Jq1 blocks memory in mice (2015) (2015)](https://doi.org/10.1038/nn.4095)
[Sullivan et al., Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice (2015) (2015)](https://doi.org/10.1084/jem.20151271)
[Filippakopoulos et al., Selective inhibition of BET bromodomains (2010) (2010)](https://doi.org/10.1038/nature09504)
[Hnisz et al., Super-enhancers in the control of cell identity and disease (2013) (2013)](https://doi.org/10.1016/j.cell.2013.09.053)
[Sabari et al., Coactivator condensation at super-enhancers links phase separation and gene control (2018) (2018)](https://doi.org/10.1126/science.aar3958)
[Belkina et al., BET domain co-regulators in obesity, inflammation and cancer (2012) (2012)](https://doi.org/10.1038/nrc3256)From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [Chromatin Accessibility Restoration via BRD4 Modulation](/hypothesis/h-addc0a61) — <span style="color:#ffd54f;font-weight:600">0.52</span> · Target: BRD4
Pathway Diagram
The following diagram shows the key molecular relationships involving BRD4 (Bromodomain-Containing Protein 4) discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)